Research Commercialization Academy (BETA 0.01)

Back Office Services for NCET2.org

 

Author: William Alden


Source: The New York Times


Interest: Mr. Kvamme and another former Sequoia partner, Chris Olsen, have finished raising an inaugural $250 million fund for Drive Capital, their new venture capital firm focused on companies in the Midwest region, according to an announcement on Tuesday. The firm, which Mr. Kvamme and Mr. Olsen founded in 2012, has already backed a handful of companies in fields related to technology, consumers and health care.


Link: http://dealbook.nytimes.com/2014/02/04/venture-capital-firm-focused-on-the-midwest-raises-a-250-million-fund/

Leave a Comment

Author: Gregg Bayes-Brown, editor


Source: Global University Venturing


Interest: The University of Maryland has been awarded an Excellence in Entrepreneurship Education award by the United States Association for Small Business and Entrepreneurship (USASBE).


Link: http://www.globaluniversityventuring.rsvp1.com/article.php/3273/marylands-excellence-in-entrepreneurship

Leave a Comment

Author: Ben Sutherly


Source: The Columbus Dispatch


Interest: Central Ohio is still waiting for a breakout moment in its quest for major backing from venture capitalists for local health-care startups — financing that’s crucial in helping those businesses grow.


Link: http://www.dispatch.com/content/stories/local/2014/02/03/medical-startups-seek-funding.html

Leave a Comment

Author: PR Web


Source: PR Web


Interest: Venture capital fund performance continued to make gains across most time horizons as of September 30, 2013, according to the Cambridge Associates LLC U.S. Venture Capital Index®, the performance benchmark of the National Venture Capital Association (NVCA). The quarterly, 1-, 3-, 5-, 10- and 15-year horizons all showed higher returns with no change in the 20-year horizon.


Link: http://www.prweb.com/releases/2014/02/prweb11546753.htm

Leave a Comment

Author: Gregg Bayes-Brown, editor


Source: Global University Venturing


Interest: Velocity, the University of Waterloo's accelerator programme, is celeberating a milestone achievement after successfully raising $100m in funding for its startups since laughing five years ago.


Link: http://www.globaluniversityventuring.rsvp1.com/article.php/3281/waterloo-hits-100m

Leave a Comment

Author: Gregg Bayes-Brown, editor


Source: Global University Venturing


Interest: Kansas University has announced KU Catalyst, a new business accelerator to offer its students access to work space, mentorship, and capital.


Link: http://www.globaluniversityventuring.rsvp1.com/article.php/3286/kansas-accelerates

Leave a Comment

Author: Davorin Kuchan


Source: Corporate Venturing & Innovation Partnering


Interest: In the last few years, Corporate Venture Capital has been growing and evolving. According to CB Insights, in Q2 2013, 25% of all venture funding included CVC participation, and the deals in which CVCs participated were 60% larger than those with traditional VCs alone. An average deal in which a CVC participated was $15.1M in Q2 2013 compared to a VC-only average of $9.5M. Impressive statistics indeed.


Link: http://cvipcommunity.com/corporate-venture-capital-sport/

Leave a Comment

Author: Cadie Thompson


Source: CNBC


Interest: But while the crowdfunding phenomenon (essentially raising small amounts of money from a large pool of investors) has worked for companies like Kickstarter and Indiegogo—which fund specific projects like films and music, trying to fund start-ups this way could prove disastrous for many people, experts say.


Link: http://www.cnbc.com/id/101360140

Leave a Comment

Author: Weston Betts


Source: DailyToReador.com


Interest: Crowdfunding is an online business model that allows people from around the world to pool together money that helps fund a person’s project idea that otherwise would never have the funds to be created. In return, these backers don’t receive equity in a company, but instead receive rewards that range from a physical products to a special perk, such as a special invitation to a screening of a film or a Skype session with the maker of the project.


Link: http://www.dailytoreador.com/opinion/article_1fe91ab8-8a37-11e3-b198-0017a43b2370.html

Leave a Comment

Author: Rhonda Abrams


Source: USA Today


Interest: For many years, entrepreneurs and aspiring small-business owners had only two options when seeking investors. They could beg financing from a small group of those closest to them, what's referred to as friends, family, and fools. Or if they had a truly promising concept, they might be lucky enough to raise money from angel investors or venture capitalists.


Link: http://www.usatoday.com/story/money/columnist/abrams/2014/01/31/small-business-crowdfunding-success/5050949/

Leave a Comment

Author: Andrea Gerlin


Source: Bloomberg Business Week


Interest: Syncona LLP, the Wellcome Trust- backed venture-capital fund, invested 12 million pounds ($20 million) in an Oxford University spinoff that is developing gene therapy to treat an inherited form of blindness. Syncona is backing NightstaRx Ltd., which is testing a treatment that uses a modified virus to deliver the choroideremia gene to cells in the retina, the light-sensitive tissue at the back of the eye.


Link: http://www.businessweek.com/news/2014-01-29/wellcome-trust-s-venture-fund-backs-oxford-blindness-treatment

Leave a Comment

Author: Rebecca Kendall


Source: UCLA Today


Interest: "For the public and the economy to realize the benefits of the discoveries taking place at UCLA in terms of products and services, we need to partner with companies," he said. "These partnerships may be with existing companies, or our office may support the formation of a new company that can take the technology forward."


Link: http://today.ucla.edu/portal/ut/ucla-industry-partnerships-bring-249443.aspx

Leave a Comment

Author: Kent Bernhard Jr


Source: Upstart Business Journal


Interest: The executive director of the UCLA Venture Capital Fund, Silton, 47, comes to his position with plenty of entrepreneurial experience under his belt. He started his first company in his 20s—and failed—but followed that up with Rainmaker Systems, an enterprise software company he took public on the Nasdaq.


Link: http://upstart.bizjournals.com/money/loot/2013/11/25/veteran-entrepreneur-explores-new-way.html

Leave a Comment

Author: FierceBiotech


Source: Amgen


Interest: Amgen's 2013 Revenues Increased 8 Percent To $18.7 Billion And Adjusted Earnings Per Share (EPS) Increased 17 Percent To $7.60 2013 GAAP EPS Were $6.64 2014 Revenues and Adjusted EPS Expected to be in the Range of $19.2-$19.6 Billion and $7.90-$8.20, Respectively


Link: http://www.fiercebiotech.com/press-releases/amgens-2013-revenues-increased-8-percent-187-billion-and-adjusted-earnings

Leave a Comment

Author: Mahesh Sharma


Source: The Age


Interest: As the government considers whether to introduce new legislation allowing groups of punters to buy equity stakes in start-up companies, a local venture capital firm will launch an equity-based crowdfunding website for high net-worth individuals to collectively invest in early-stage, high-risk ventures.


Link: http://www.theage.com.au/it-pro/business-it/crowdfunding-for-highrisk-startup-investments-20140127-hva1y.html

Leave a Comment

Author: Molly Ryan


Source: Houston Business Journal


Interest: Software companies received the most venture capital investment dollars in Houston in 2013, according to the year-end MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association, which is based on data from Thomson Reuters. Some of these investments were in software companies related to Houston’s strongest industries, such as a $5 million deal for Houston’s LiquidFrameworks Inc., a software solution provider for the oil and gas industry.


Link: http://www.bizjournals.com/houston/blog/nuts-and-bolts/2014/01/even-in-the-energy-capital-of-the.html?page=all

Leave a Comment

Author: Staff Writer


Source: Dallas Business Journal


Interest: Corporate venture capital represented 15 to 20 percent of all the nation's deals last year representing between 6 and 9 percent of the dollars invested, Taylor said. Taylor gave an overview of the state of venture capital, citing the MoneyTree Report released by PricewaterhouseCoopers LLP and the NVCA last week. The report showed venture capital investments were at a 12-year high for the Dallas area, surpassing amounts from cities including Austin, Houston and San Antonio.


Link: http://www.bizjournals.com/dallas/blog/2014/01/expert-corporate-venture-capital.html

Leave a Comment

Author: VCPost Staff Reporter


Source: Venture Capital Post


Interest: Singularity University (SU) will launch its own $50-million venture fund later in 2014 to help tackle the major problems of the world, according to GigaOM. SU is an education center and accelerator headquartered at the NASA Ames Research Center in Mountain View. The university will start raising capital on the second quarter of this year. The planned fund will focus of firms launched by students, graduates, and faculty members of SU, the report detailed.


Link: http://www.vcpost.com/articles/21071/20140124/based-accelerator-singularity-university-launch-50m-venture-fund-tackle-world.htm

Leave a Comment

Author: Adam Belz


Source: Star Tribune


Interest: Minnesota companies attracted $116.9 million in venture capital in the fourth quarter, the best three-month period for the state since 2008. The late-year infusion in venture capital rescued the state from what had been a considerably down year, according to the MoneyTree Report by the National Venture Capital Association and PricewaterhouseCoopers (PwC), using data from Thomson Reuters.


Link: http://www.startribune.com/business/241913111.html

Leave a Comment

Author: ImmunGene, Inc.


Source: http://www.prnewswire.com/


Interest: ImmunGene, Inc., a biotechnology company focused on developing antibody-cytokine fusion technology therapies to treat cancer, today announced it has secured $9 million in a milestone-based Series A financing from Ally Bridge Group. Previous investments in the Company were converted into Series A preferred stock. ImmunGene will use the capital to advance its early-stage development products to IND-enabling studies.


Link: http://www.prnewswire.com/news-releases/immungene-raises-9-million-in-series-a-financing-230953201.html

Leave a Comment